Board meeting set for November 5, 2026 to approve quarterly results

EBITDA margin compressionNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.9%Next day

₹25.87

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.9%-3.0% vs market

Pharmaceuticals peers, median of 172sector-0.6%-4.2% vs sector

By the next day the stock moved 3.0 pts less than Nifty Microcap 250 and 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—+0.7—+0.4—

Next day

-4.9-1.9-3.0-0.6-4.2

-9.6-0.4-9.2-0.4-9.2

-9.9-0.2-9.8-0.1-9.9

-10.5+2.0-12.5+0.7-11.2

-10.9+3.1-14.0+1.8-12.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on November 5, 2026, to approve the company's unaudited financial results for the quarter ended September 30, 2026. The insider trading window remains closed through November 16 and reopens on November 17. No financial figures or audit-related changes are disclosed.

Likely market impact

Results are still pending, so investors must wait for the November 5 announcement. The insider trading window reopens November 17.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹5.62 Cr	₹4.89 Cr	+15.0%
Operating profit	−₹0.11 Cr	−₹0.02 Cr	loss widened
Profit after tax	₹0.03 Cr	₹0.07 Cr	−57.6%
EBITDA margin	-1.4%	0.3%	−1.7 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.